Dihydrocodeine Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET INTRODUCTION
Dihydrocodeine (DHC) is a type of an analgesic. It is a semi-synthetic analogue of codeine formed by the hydrogenation of the double tie in the main chain of the codeine molecule - instead of a double between carbons seven and eight, dihydrocodeine possesses a single bond. Dihydrocodeine is widely used in appropriate doses as an analgesic and antitussive agent and for the management of dyspnea and opioid addiction.
MARKET DYNAMICS
The dihydrocodeine market has shown a significant evolution over the forecast period. The rise of the dihydrocodeine market is driven by the need for analgesics for patients suffering from chronic pain of a minimal to high intensity, especially with concomitant cough and dyspnea. It is a pervasive situation in patients with advanced lung cancer. Besides, the aging population's frequent pain and aches, increasing incidences of respiratory disorders, cancer, & arthritis are further fueling the market's growth. Furthermore, the growing investments in research and development activities by the public & private sectors, with a major focus on the classes of compounds to formulate new therapeutics, are the major factors boosting the market growth. However, adverse side effects like constipation, stomach pain, dry mouth, nausea, and vomiting are likely to hamper the market's growth. Also, factors such as uncontrolled prescriptions of opioids and drug abuse, leading to approximately 28,000 deaths in the U.S. every year, and insufficient regulatory guidelines, especially against opioid analgesics, are likely to impede the market growth.
MARKET SCOPE
The "Dihydrocodeine Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry's pharmaceuticals, focusing on the global market trend analysis. This report outlines the dihydrocodeine market with detailed market segmentation by product, application, and end-user. The dihydrocodeine market is estimated to witness a high rise during the forecast period. It focuses on the vital statistics on leading players' market status in the dihydrocodeine market and provides key opportunities and trends in the market.
MARKET SEGMENTATION
The market is categorized based on the product, application, and end user. Based on the product, the market is segmented as oral and injection. Based on the application, the segmentation of the market is into analgesic, antitussive, and others. Based on end user, the segmentation of the market is into hospitals, clinics, and others.
REGIONAL FRAMEWORK
The report states a detailed outline of the industry, consisting of both quantitative and qualitative information. It offers a sketch and forecast of the dihydrocodeine market based on various segments. The report also consists of market size and forecast estimates from the year 2021 to2031with respect to five main regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The dihydrocodeine market by each region is then sub-segmented into respective countries and segments. It comprises the analysis and forecast of 18 countries globally and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the dihydrocodeine market from both the demand and supply sides. Furthermore, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also consists of precise PEST analysis for all five regions, namely, North America, Asia Pacific, Europe, Middle East, and Africa, and South & Central America, after assessing political, social, economic, and technological factors affecting the dihydrocodeine market in these regions.
By Product
By Application
By End User
MARKET PLAYERS
The report contains critical developments in the dihydrocodeine market as inorganic and organic growth strategies. Several companies are pivoting on organic growth strategies like product launches, product approvals, and others, such as patents and events. Inorganic growth strategies observed were collaborations and acquisitions &partnerships. Various such activities have paved the path for elaborating the business and customer base of market players. The market players from the dihydrocodeine market are estimated to have profitable growth opportunities in the coming years with the higher demand for dihydrocodeine in the global market. Given below is the list of a few companies engaged in the dihydrocodeine market.
The report also offers key players' profiles in the dihydrocodeine market, along with their SWOT analysis and market strategies. Also, the report focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.
The Insight Partner's dedicated research and the analytical team comprises of experienced professionals with advanced statistical expertise and offers several customization options in the current report.
Dihydrocodeine (DHC) is a type of an analgesic. It is a semi-synthetic analogue of codeine formed by the hydrogenation of the double tie in the main chain of the codeine molecule - instead of a double between carbons seven and eight, dihydrocodeine possesses a single bond. Dihydrocodeine is widely used in appropriate doses as an analgesic and antitussive agent and for the management of dyspnea and opioid addiction.
MARKET DYNAMICS
The dihydrocodeine market has shown a significant evolution over the forecast period. The rise of the dihydrocodeine market is driven by the need for analgesics for patients suffering from chronic pain of a minimal to high intensity, especially with concomitant cough and dyspnea. It is a pervasive situation in patients with advanced lung cancer. Besides, the aging population's frequent pain and aches, increasing incidences of respiratory disorders, cancer, & arthritis are further fueling the market's growth. Furthermore, the growing investments in research and development activities by the public & private sectors, with a major focus on the classes of compounds to formulate new therapeutics, are the major factors boosting the market growth. However, adverse side effects like constipation, stomach pain, dry mouth, nausea, and vomiting are likely to hamper the market's growth. Also, factors such as uncontrolled prescriptions of opioids and drug abuse, leading to approximately 28,000 deaths in the U.S. every year, and insufficient regulatory guidelines, especially against opioid analgesics, are likely to impede the market growth.
MARKET SCOPE
The "Dihydrocodeine Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry's pharmaceuticals, focusing on the global market trend analysis. This report outlines the dihydrocodeine market with detailed market segmentation by product, application, and end-user. The dihydrocodeine market is estimated to witness a high rise during the forecast period. It focuses on the vital statistics on leading players' market status in the dihydrocodeine market and provides key opportunities and trends in the market.
MARKET SEGMENTATION
The market is categorized based on the product, application, and end user. Based on the product, the market is segmented as oral and injection. Based on the application, the segmentation of the market is into analgesic, antitussive, and others. Based on end user, the segmentation of the market is into hospitals, clinics, and others.
REGIONAL FRAMEWORK
The report states a detailed outline of the industry, consisting of both quantitative and qualitative information. It offers a sketch and forecast of the dihydrocodeine market based on various segments. The report also consists of market size and forecast estimates from the year 2021 to2031with respect to five main regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The dihydrocodeine market by each region is then sub-segmented into respective countries and segments. It comprises the analysis and forecast of 18 countries globally and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the dihydrocodeine market from both the demand and supply sides. Furthermore, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also consists of precise PEST analysis for all five regions, namely, North America, Asia Pacific, Europe, Middle East, and Africa, and South & Central America, after assessing political, social, economic, and technological factors affecting the dihydrocodeine market in these regions.
Dihydrocodeine Market Report Analysis
Dihydrocodeine Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Napp Pharmaceuticals Ltd
- Johnson Matthey PLC
- SPECGX LLC
- Chattem Chemicals Inc
- Penick Corporation
- Biotechnica Pharma Global
- Mallinckrodt Plc
- Saneca Pharmaceuticals
- SUN Pharmaceutical Industries Ltd
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Product
- Oral
- Injection
By Application
- Analgesic
- Antitussive
By End User
- Hospitals
- Clinics
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The report contains critical developments in the dihydrocodeine market as inorganic and organic growth strategies. Several companies are pivoting on organic growth strategies like product launches, product approvals, and others, such as patents and events. Inorganic growth strategies observed were collaborations and acquisitions &partnerships. Various such activities have paved the path for elaborating the business and customer base of market players. The market players from the dihydrocodeine market are estimated to have profitable growth opportunities in the coming years with the higher demand for dihydrocodeine in the global market. Given below is the list of a few companies engaged in the dihydrocodeine market.
The report also offers key players' profiles in the dihydrocodeine market, along with their SWOT analysis and market strategies. Also, the report focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.
- Napp Pharmaceuticals Ltd.
- Johnson Matthey PLC
- SPECGX LLC
- Chattem Chemicals, Inc.
- Penick Corporation
- Biotechnica Pharma Global
- Mallinckrodt Plc
- Saneca Pharmaceuticals
- SUN Pharmaceutical Industries Ltd.
- Hasti Aria Shimi (H.A.S.)
The Insight Partner's dedicated research and the analytical team comprises of experienced professionals with advanced statistical expertise and offers several customization options in the current report.
Dihydrocodeine Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Napp Pharmaceuticals Ltd.
2. Johnson Matthey PLC
3. SPECGX LLC
4. Chattem Chemicals, Inc.
5. Penick Corporation
6. Biotechnica Pharma Global
7. Mallinckrodt Plc
8. Saneca Pharmaceuticals
9. SUN Pharmaceutical Industries Ltd.
10. Hasti Aria Shimi (H.A.S.)
1. Napp Pharmaceuticals Ltd.
2. Johnson Matthey PLC
3. SPECGX LLC
4. Chattem Chemicals, Inc.
5. Penick Corporation
6. Biotechnica Pharma Global
7. Mallinckrodt Plc
8. Saneca Pharmaceuticals
9. SUN Pharmaceutical Industries Ltd.
10. Hasti Aria Shimi (H.A.S.)
Get Free Sample For